Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure

Citation
Giorgino F, Caruso I, Moellmann J, Lehrke M. Metabolism 2020;104:154045.